glp-1 afib Agonists in Cardiovascular Diseases: Mechanisms, Clinical Evidence, and Emerging Therapies GLP-1 use cuts atrial fibrillation

[DOI] [PubMed] [Google Scholar] 119.Aronne LJ, Sattar N, Horn DB, et al

Inflammation is a defense response of the body to injury or infection, but an excessive inflammatory response can lead to tissue damage and delayed healing

Pal VK, Bandyopadhyay P, Singh A

The median age of patients was 57 years (range: 1499 years) in our pharmacovigilance analysis and 60 years (range: 2777 years) for the cases of GLP-1 RAs-induced AP published in the case reports, which is in line with earlier observational studies on drug-induced AP (Gagnon et al., 2020

This means that a board of trusted medical professionals deem the company to be compliant with all applicable laws